Avid Bioservices (STU:TEHN) Change In Payables And Accrued Expense : €-1.4 Mil (TTM As of Oct. 2024)

View and export this data going back to . Start your Free Trial

What is Avid Bioservices Change In Payables And Accrued Expense?

Avid Bioservices's Change In Payables And Accrued Expense for the quarter that ended in Oct. 2024 was €-7.1 Mil. It means Avid Bioservices's Accounts Payable & Accrued Expense declined by €7.1 Mil from Jul. 2024 to Oct. 2024 .

Avid Bioservices's Change In Payables And Accrued Expense for the fiscal year that ended in Apr. 2024 was €3.2 Mil. It means Avid Bioservices's Accounts Payable & Accrued Expense increased by €3.2 Mil from Apr. 2023 to Apr. 2024 .

Avid Bioservices Change In Payables And Accrued Expense Historical Data

The historical data trend for Avid Bioservices's Change In Payables And Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Avid Bioservices Change In Payables And Accrued Expense Chart

Avid Bioservices Annual Data

Trend

Apr15

Apr16

Apr17

Apr18

Apr19

Apr20

Apr21

Apr22

Apr23

Apr24

Change In Payables And Accrued Expense

Get a 7-Day Free Trial

0.70

4.51

-0.04

2.43

3.23

Avid Bioservices Quarterly Data
	Jan20	Apr20	Jul20	Oct20	Jan21	Apr21	Jul21	Oct21	Jan22	Apr22	Jul22	Oct22	Jan23	Apr23	Jul23	Oct23	Jan24	Apr24	Jul24	Oct24
Change In Payables And Accrued Expense	Get a 7-Day Free Trial															-1.40	-1.05	4.45	2.25	-7.10

Avid Bioservices Change In Payables And Accrued Expense Calculation

Change In Payables And Accrued Expense is the increase or decrease between periods of the Accounts Payable & Accrued Expense. Accrued expenses represent expenses incurred at the end of the reporting period but not yet paid; also called accrued liabilities. The accrued liability is shown under Liabilities section in the balance sheet.

Change In Payables And Accrued Expense for the trailing twelve months (TTM) ended in Oct. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-1.4 Mil.

Avid Bioservices Change In Payables And Accrued Expense Related Terms

Thank you for viewing the detailed overview of Avid Bioservices's Change In Payables And Accrued Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Avid Bioservices Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Avid Bioservices Inc (STU:TEHN) » Definitions » Change In Payables And Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

14191 Myford Road, Tustin, CA, USA, 92780

Website

https://www.avidbio.com

Avid Bioservices Inc is a clinical-stage biopharmaceutical company focused on the development and Current Good Manufacturing Practices (CGMP) of biopharmaceutical products derived from mammalian cell culture. Its business is organized into one reportable operating segment which is contract manufacturing and development services segment. Its services include clinical and commercial drug substance manufacturing, bulk packaging, release and stability testing and regulatory submissions support. The company also provides a variety of process development services including cell line development, upstream and downstream development and optimization, analytical method development, testing and characterization.

Avid Bioservices Headlines

No Headlines